Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in the province of Málaga (Spain)].
Palacios R, Viciana I, Pérez de Pedro I, de la Torre J, Ropero F, Fernández S, Salgado F, Roldán J, de Dios Colmenero J, Márquez M, Santos J; Grupo Malagueño para el Estudio de las Enfermedades Infecciosas. Palacios R, et al. Among authors: de la torre j, de dios colmenero j. Enferm Infecc Microbiol Clin. 2008 Mar;26(3):141-5. doi: 10.1157/13116750. Enferm Infecc Microbiol Clin. 2008. PMID: 18358212 Spanish.
[Immunological, virological and clinical response in patients infected with HIV after highly active antiviral therapy with nelfinavir: prospective cohort study].
de Alarcón A, Viciana P, Lozano F, Vergara A, Pujol E, Barrera A, Pérez-Guzmán E, Colmenero MA, Hernández-Quero J, Márquez M, de la Torre J, Aliaga L, Suárez I, Gutiérrez-Ravé V, Torres-Tortosa M, Marín J, Valdayo MJ, Milla M; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. de Alarcón A, et al. Among authors: de la torre j. Enferm Infecc Microbiol Clin. 2003 Dec;21(10):543-51. Enferm Infecc Microbiol Clin. 2003. PMID: 14642252 Clinical Trial. Spanish.
HIV infection in the era of highly active antiretroviral therapy: the Malaga Study.
Santos J, Palacios R, Gutierrez M, Grana M, de la Torre J, Salgado F, Nuño E, Márquez M; Grupo Malagueño para el estudio de Enfermedades Infecciones. Santos J, et al. Among authors: de la torre j. Int J STD AIDS. 2004 Sep;15(9):594-6. doi: 10.1258/0956462041724253. Int J STD AIDS. 2004. PMID: 15339366
[Left-sided native valve endocarditis by coagulase-negative staphylococci: an emerging disease].
Haro JL, Lomas JM, Plata A, Ruiz J, Gálvez J, de la Torre J, Hidalgo-Tenorio C, Reguera JM, Márquez M, Martínez-Marcos F, de Alarcón A; by Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas. Haro JL, et al. Among authors: de la torre j, de alarcon a. Enferm Infecc Microbiol Clin. 2008 May;26(5):263-8. doi: 10.1157/13120417. Enferm Infecc Microbiol Clin. 2008. PMID: 18479642 Spanish.
[First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes].
de la Torre J, Santos J, Perea-Milla E, Pérez I, Moreno F, Palacios R, Santamaría S, Del Arco A, Nuño E, Godoy M, Prada JL, Olalla J, Aguilar J, Martos F; Grupo Malagueño de Enfermedades Infecciosa. de la Torre J, et al. Enferm Infecc Microbiol Clin. 2008 Aug-Sep;26(7):416-22. doi: 10.1157/13125638. Enferm Infecc Microbiol Clin. 2008. PMID: 18842236 Spanish.
[Left-sided endocarditis due to gram-negative bacilli: epidemiology and clinical characteristics].
Noureddine M, de la Torre J, Ivanova R, Martínez FJ, Lomas JM, Plata A, Gálvez J, Reguera JM, Ruiz J, Hidalgo C, Luque R, García-López MV, de Alarcón A; Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Noureddine M, et al. Among authors: de la torre j, de alarcon a. Enferm Infecc Microbiol Clin. 2011 Apr;29(4):276-81. doi: 10.1016/j.eimc.2010.12.007. Epub 2011 Feb 22. Enferm Infecc Microbiol Clin. 2011. PMID: 21334783 Spanish.
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM. Rivero A, et al. Among authors: de la torre j. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):88-99. doi: 10.1016/j.eimc.2016.06.013. Epub 2016 Jul 25. Enferm Infecc Microbiol Clin. 2017. PMID: 27459919 Free article.
Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).
Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Palacios R, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S; GeSIDA 7011 Study Group. Perez-Molina JA, et al. J Antimicrob Chemother. 2017 Jan;72(1):246-253. doi: 10.1093/jac/dkw379. Epub 2016 Sep 13. J Antimicrob Chemother. 2017. PMID: 27629070 Free article. Clinical Trial.
975 results